Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review

References

• Siegel RL, Miller KD, Jemal A. (2016). Cancer statistics, 2016. CA Cancer J Clin 66:7–30.
   PubMed Web of Science ®Google Scholar
• Siegel R, Desantis C, Jemal A. (2014). Colorectal cancer statistics, 2014. CA Cancer J Clin 64:104–17.
   PubMed Web of Science ®Google Scholar
• Sabiston DC, Townsend CM. (2012). Sabiston textbook of surgery: the biological basis of modern surgical practice. Philadelphia (PA): Elsevier Saunders.
   Google Scholar
• Edwards BK, Ward E, Kohler BA, et al. (2010). Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116:544–73.
   PubMed Web of Science ®Google Scholar
• van der Pool AEM, Damhuis RA, Ijzermans JNM, et al. (2012). Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis 14:56–61.
   PubMed Web of Science ®Google Scholar
• Brenner H, Kloor M, Pox CP. (2014). Colorectal cancer. Lancet 383:1490–502.
   PubMed Web of Science ®Google Scholar
• Elferink MAG, de Jong KP, Klaase JM, et al. (2015). Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands. Int J Colorectal Dis 30:205–12.
   PubMed Web of Science ®Google Scholar
• Yothers G, O'Connell MJ, Allegra CJ, et al. (2011). Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. JCO 29:3768–74.
   PubMed Web of Science ®Google Scholar
• Brodsky JT, Cohen AM. (1991). Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy. Dis Colon Rectum 34:723–7.
   PubMed Web of Science ®Google Scholar
• Sloothaak DA, Mirck B, Punt CJ, et al. (2014). Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review. Br J Cancer 111:1112–21.
   PubMed Web of Science ®Google Scholar
• Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP. (2006). Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 243:212–22.
   PubMed Web of Science ®Google Scholar
• Segelman J, Granath F, Holm T, et al. (2012). Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg 99:699–705.
   PubMed Web of Science ®Google Scholar
• Bouvier AM, Launoy G, Bouvier V, et al. (2015). Incidence and patterns of late recurrences in colon cancer patients. Int J Cancer 137:2133–8.
   PubMed Web of Science ®Google Scholar
• Franko J, Shi Q, Goldman CD, et al. (2012). Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol 30:263–7.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. (2001). Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 27:239–43.
   PubMed Web of Science ®Google Scholar
• El Halabi H, Gushchin V, Francis J, et al. (2012). The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. Ann Surg Oncol 19:110–14.
   PubMed Web of Science ®Google Scholar
• Bijelic L, Jonson A, Sugarbaker PH. (2007). Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol 18:1943–50.
   PubMed Web of Science ®Google Scholar
• Ji ZH, Peng KW, Yu Y, et al. (2017). Current status and future prospects of clinical trials on CRS + HIPEC for gastric cancer peritoneal metastases. Int J Hyperthermia 33:562–70.
   PubMed Web of Science ®Google Scholar
• Polom K, Marano L, Roviello G, et al. (2016). Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: from treating the incurable to preventing recurrence. Int J Hyperthermia 32:173–9.
   PubMed Web of Science ®Google Scholar
• Feingold PL, Kwong ML, Davis JL, Rudloff U. (2017). Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: a systematic review. J Surg Oncol 115:192–201.
   PubMed Web of Science ®Google Scholar
• Yan TD, Black D, Sugarbaker PH, et al. (2007). A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 14:2702–13.
   PubMed Web of Science ®Google Scholar
• Zheng X, Carstens JL, Kim J, et al. (2015). Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527:525–30.
   PubMed Web of Science ®Google Scholar
• Fischer KR, Durrans A, Lee S, et al. (2015). Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527:472–6.
   PubMed Web of Science ®Google Scholar
• Psaila B, Lyden D. (2009). The metastatic niche: adapting the foreign soil. Nat Rev Cancer 9:285–93.
   PubMed Web of Science ®Google Scholar
• Fidler IJ. (2003). The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453–8.
   PubMed Web of Science ®Google Scholar
• Fushida KO, Kinoshita J, Tsukada T, et al. (2013). Intraperitoneal chemotherapy as a multimodal treatment for gastric cancer patients with peritoneal metastasis. J Cancer Ther 4:6–15.
   Google Scholar
• Lu Z, Wang J, Wientjes MG, Au JL. (2010). Intraperitoneal therapy for peritoneal cancer. Future Oncol 6:1625–41.
   PubMed Web of Science ®Google Scholar
• Goodman MD, McPartland S, Detelich D, Saif MW. (2016). Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy. J Gastrointest Oncol 7:45–57.
   PubMed Web of Science ®Google Scholar
• Armstrong DK, Bundy B, Wenzel L, et al. (2006). Intraperitoneal cisplatin and paclitaxel in ovarian cancer. New Engl J Med 354:34–43.
   PubMed Web of Science ®Google Scholar
• Coccolini F, Cotte E, Glehen O, et al. (2014). Intraperitoneal chemotherapy in advanced gastric cancer: meta-analysis of randomized trials. Eur J Surg Oncol 40:12–26.
   PubMed Web of Science ®Google Scholar
• Klaver CE, Musters GD, Bemelman WA, et al. (2015). Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial. BMC Cancer 15:428.
   PubMed Web of Science ®Google Scholar
• R Foundation for Statistical Computing. (2014). R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
   Google Scholar
• Wickham H. (2009). ggplot2: elegant graphics for data analysis. New York: Springer-Verlag.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement the PRISMA statement. Ann Internal Med 151:264–9.
   PubMed Web of Science ®Google Scholar
• Tentes AA, Spiliotis ID, Korakianitis OS, et al. (2011). Adjuvant perioperative intraperitoneal chemotherapy in locally advanced colorectal carcinoma: preliminary results. ISRN Surg 2011:529876.
   PubMedGoogle Scholar
• Nordlinger B, Rougier P, Arnaud JP, et al. (2005). Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial. Lancet Oncol 6:459–68.
   PubMed Web of Science ®Google Scholar
• Vaillant JC, Nordlinger B, Deuffic S, et al. (2000). Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: a multicenter phase III trial. Ann Surg 231:449–56.
   PubMed Web of Science ®Google Scholar
• Scheithauer W, Kornek GV, Marczell A, et al. (1998). Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma. Br J Cancer 77:1349–54.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH, Gianola FJ, Speyer JL, et al. (1985). Prospective randomized trial of intravenous v intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer. Semin Oncol 12:101–11.
   PubMed Web of Science ®Google Scholar
• Sammartino P, Sibio S, Biacchi D, et al. (2012). Prevention of peritoneal metastases from colon cancer in high-risk patients: preliminary results of surgery plus prophylactic HIPEC. Gastroenterol Res Pract 2012:141585.
   PubMed Web of Science ®Google Scholar
• Noura S, Ohue M, Shingai T, et al. (2011). Effects of intraperitoneal chemotherapy with mitomycin C on the prevention of peritoneal recurrence in colorectal cancer patients with positive peritoneal lavage cytology findings. Ann Surg Oncol 18:396–404.
   PubMed Web of Science ®Google Scholar
• Virzi S, Iusco D, Baratti D, et al. (2013). Pilot study of adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at high risk for the development of peritoneal metastases. Tumori 99:589–95.
   PubMed Web of Science ®Google Scholar
• Palermo JA, Richards F, Lohman KK, et al. (2000). Phase II trial of adjuvant radiation and intraperitoneal 5-fluorouracil for locally advanced colon cancer: results with 10-year follow-up. Int J Radiat Oncol Biol Phys 47:725–33.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. (2002). Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–58.
   PubMed Web of Science ®Google Scholar
• Higgins J, Green SE. 2011. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011] - 10.4.4.1. Comparing fixed and random-effects estimates. The Cochrane Collaboration. Available from: www.handbook.cochrane.org [last accessed 11 Aug 2016].
   Google Scholar
• Begg CB, Mazumdar M. (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–101.
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, Minder C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–34.
   PubMed Web of Science ®Google Scholar
• Peters JL, Sutton AJ, Jones DR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295:676–80.
   PubMed Web of Science ®Google Scholar
• Harbord RM, Egger M, Sterne JA. (2006). A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25:3443–57.
   PubMed Web of Science ®Google Scholar
• Tentes AA, Kyziridis D, Kakolyris S, et al. (2012). Preliminary results of hyperthermic intraperitoneal intraoperative chemotherapy as an adjuvant in resectable pancreatic cancer. Gastroenterol Res Pract 2012:506571.
   PubMed Web of Science ®Google Scholar
• Simon RM, Paik S, Hayes DF. (2009). Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Nat Cancer Inst 101:1446–52.
   PubMed Web of Science ®Google Scholar
• O'Connell MJ, Lavery I, Yothers G, et al. (2010). Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin. J Clin Oncol 28:3937–44.
   PubMed Web of Science ®Google Scholar
• Kanat O, Gewirtz A, Kemeny N. (2012). What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer. J Gastrointest Oncol 3:130–8.
   PubMedGoogle Scholar
• Coccolini F, Cotte E, Glehen O, et al. (2014). Intraperitoneal chemotherapy in advanced gastric cancer: meta-analysis of randomized trials. Eur J Surg Oncol 40:12–26.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. (2007). Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy. Int J Hyperthermia 23:431–42.
   PubMed Web of Science ®Google Scholar
• Zhao C, Dai C, Chen X. (2012). Whole-body hyperthermia combined with hyperthermic intraperitoneal chemotherapy for the treatment of stage IV advanced gastric cancer. Int J Hyperthermia 28:735–41.
   PubMed Web of Science ®Google Scholar
• Zhong H, Yang Y, Ma S, et al. (2011). Induction of a tumour-specific CTL response by exosomes isolated from heat-treated malignant ascites of gastric cancer patients. Int J Hyperthermia 27:604–11.
   PubMed Web of Science ®Google Scholar
• Rudloff U, Langan RC, Mullinax JE, et al. (2014). Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol 110:275–84.
   PubMed Web of Science ®Google Scholar
• Glehen O, Gilly FN, Arvieux C, et al. (2010). Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17:2370–7.
   PubMed Web of Science ®Google Scholar
• Levine EA, Blazer DG, 3rd, Kim MK, et al. (2012). Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes. J Am College Surgeons 214:599–606. discussion -7.
   PubMed Web of Science ®Google Scholar
• Yachida S, Jones S, Bozic I, et al. (2010). Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467:1114–7.
   PubMed Web of Science ®Google Scholar
• Nguyen DX, Bos PD, Massague J. (2009). Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9:274–84.
   PubMed Web of Science ®Google Scholar